Achilles Therapeutics (ACHL) Stock Chart & Stock Price History → The Gold Grab of the Century (From Colonial Metals) (Ad) Free ACHL Stock Alerts $0.83 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Achilles Therapeutics Stock Price Performance5 Day Performance+2.77%1 Month Performance-0.79%3 Month Performance-12.13%6 Month Performance-3.57%Year-To-Date Performance-7.09%1 Year Performance-13.97% Receive ACHL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceThe new financial threat that could wipe out millions…During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video ACHL Stock Chart for Wednesday, May, 8, 2024 ACHL Chart by TradingView Achilles Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$0.83$0.83-0.36%$0.84$0.8167,649 shs$32.94 million05/06/2024$0.80$0.83+3.15%$0.84$0.79195,593 shs$33.06 million05/03/2024$0.78$0.80+3.03%$0.85$0.79185,201 shs$32.05 million05/02/2024$0.78$0.78-0.22%$0.81$0.76163,349 shs$31.11 million05/01/2024$0.75$0.78+4.24%$0.79$0.75101,813 shs$31.18 million04/30/2024$0.76$0.75-1.32%$0.78$0.75117,993 shs$29.91 million Get the Latest News and Ratings for ACHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.76$0.76$0.78$0.75364,419 shs$30.31 million04/26/2024$0.77$0.76-1.86%$0.80$0.74382,132 shs$30.31 million04/25/2024$0.79$0.77-1.91%$0.80$0.74260,086 shs$30.88 million04/24/2024$0.78$0.79+0.83%$0.81$0.76119,428 shs$31.49 million04/23/2024$0.80$0.78-2.00%$0.83$0.77111,844 shs$31.23 million04/22/2024$0.78$0.80+2.06%$0.82$0.76429,298 shs$31.86 million04/19/2024$0.80$0.78-2.14%$0.83$0.78200,792 shs$31.22 million04/18/2024$0.82$0.80-2.91%$0.82$0.79187,410 shs$31.90 million04/17/2024$0.80$0.82+2.72%$0.83$0.79184,532 shs$32.86 million04/16/2024$0.83$0.80-3.35%$0.85$0.80129,966 shs$31.99 million04/15/2024$0.85$0.83-2.35%$0.86$0.82250,943 shs$33.10 million04/12/2024$0.85$0.85$0.86$0.84163,969 shs$34.66 million04/11/2024$0.82$0.85+3.71%$0.86$0.81367,396 shs$34.66 million04/10/2024$0.84$0.82-2.59%$0.84$0.81290,863 shs$33.42 million04/09/2024$0.83$0.84+1.06%$0.86$0.81183,621 shs$34.31 million04/08/2024$0.84$0.83-1.00%$0.86$0.81479,382 shs$33.96 million04/05/2024$0.90$0.84-6.86%$0.90$0.83523,775 shs$34.30 million04/04/2024$1.20$0.90-24.76%$0.99$0.852.27 million shs$36.82 million04/03/2024$1.19$1.20+0.84%$1.20$1.1382,561 shs$48.94 million04/02/2024$1.25$1.19-4.80%$1.23$1.15112,424 shs$48.53 million04/01/2024$1.25$1.25$1.27$1.19483,479 shs$50.98 million03/29/2024$1.25$1.25$1.29$1.19282,880 shs$50.98 million03/28/2024$1.21$1.25+3.31%$1.29$1.19280,176 shs$50.98 million03/27/2024$1.24$1.21-2.42%$1.25$1.16360,085 shs$49.34 million03/26/2024$1.23$1.24+0.81%$1.29$1.18132,985 shs$50.57 million03/25/2024$1.28$1.23-3.91%$1.29$1.18136,997 shs$50.16 million03/22/2024$1.27$1.28+0.79%$1.32$1.20211,704 shs$52.20 million03/21/2024$1.29$1.27-1.55%$1.32$1.25107,211 shs$51.79 million03/20/2024$1.19$1.29+8.40%$1.29$1.12408,181 shs$52.61 million03/19/2024$1.10$1.19+8.18%$1.19$1.07321,511 shs$48.53 million03/18/2024$1.10$1.10$1.14$1.07360,041 shs$44.86 million03/15/2024$1.11$1.10-0.90%$1.14$1.05343,440 shs$44.86 million03/14/2024$1.22$1.11-9.02%$1.22$1.08245,551 shs$45.27 million03/13/2024$1.23$1.22-0.81%$1.24$1.17185,437 shs$49.75 millionStock-Picking AI Predicts #1 Stock of 2024 (Ad)Since the start of the year, the top 10 investment funds in the world – including Vanguard, Blackrock, Fidelity and JP Morgan – have made nearly $1 trillion in profits on these 7 stocks.Click here to learn what's coming (and how to prepare).03/12/2024$1.23$1.23$1.27$1.17207,298 shs$50.16 million03/11/2024$1.23$1.23$1.27$1.20227,204 shs$50.16 million03/08/2024$1.22$1.24+1.64%$1.28$1.21146,263 shs$50.57 million03/07/2024$1.24$1.22-1.61%$1.28$1.18462,605 shs$49.75 million03/06/2024$1.29$1.24-3.88%$1.29$1.17471,202 shs$50.57 million03/05/2024$1.48$1.29-12.84%$1.47$1.26482,407 shs$52.61 million03/04/2024$1.36$1.48+8.82%$1.52$1.36448,756 shs$60.35 million03/01/2024$1.32$1.36+3.03%$1.42$1.31549,462 shs$55.46 million02/29/2024$1.57$1.32-15.92%$1.76$1.262.37 million shs$53.83 million02/28/2024$1.49$1.57+5.37%$1.58$1.401.16 million shs$64.03 million02/27/2024$1.36$1.49+9.56%$1.55$1.362.11 million shs$60.76 million02/26/2024$1.36$1.36$1.43$1.301.63 million shs$55.46 million02/23/2024$1.36$1.36$1.42$1.261.96 million shs$55.46 million02/22/2024$1.23$1.36+10.57%$1.43$1.165.60 million shs$55.46 million02/21/2024$1.08$1.23+13.89%$1.25$1.112.85 million shs$50.16 million02/20/2024$1.06$1.08+1.89%$1.14$1.023.10 million shs$44.04 million02/19/2024$1.06$1.06$1.08$0.942.66 million shs$43.23 million02/16/2024$0.96$1.06+10.44%$1.08$0.942.53 million shs$43.23 million02/15/2024$0.97$0.96-1.55%$0.98$0.94778,529 shs$39.14 million02/14/2024$0.95$0.97+2.62%$0.99$0.93250,828 shs$39.76 million02/13/2024$0.96$0.95-0.67%$0.99$0.91453,164 shs$38.74 million02/12/2024$0.94$0.96+1.74%$0.97$0.93631,919 shs$39.00 million02/09/2024$0.94$0.94$0.96$0.881.84 million shs$38.33 million02/08/2024$0.92$0.94+2.17%$0.95$0.88565,440 shs$38.33 million02/07/2024$0.92$0.92+0.25%$0.95$0.90408,032 shs$37.52 million Related Companies: TARA Stock Price Chart INKT Stock Price Chart SRZN Stock Price Chart PLUR Stock Price Chart NKGN Stock Price Chart ESLA Stock Price Chart SABS Stock Price Chart CRTX Stock Price Chart QNCX Stock Price Chart BCLI Stock Price Chart Receive ACHL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACHL) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow Investor[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.